Service
Competitive Intelligence
Who your competitors are, what they have built, what their choices mean for your program, and how you compare. For biotech teams, investors, and BD teams
What's inside the deliverable
Every section is sourced, specific, and built for direct use in decisions
Landscape map
Competitors by mechanism, modality, indication, and stage. Each entry includes company, program, target, lead indication, current phase, trial design summary, latest readout, key risks, and sources.
Precedent review
How competitors built their preclinical and clinical programs: species, model choices, endpoints, dose rationale, regulatory path, and the decisions that shaped their timelines and outcomes.
Positioning
How your program compares on mechanism, clinical positioning, regulatory path, and development risk. Talking points you can use in board decks, investor conversations, and partner meetings.
Stakeholder map
KOLs, advisory board candidates, patient advocacy, and active investigators for your indication and modality. Names, affiliations, and relevance, not just a list.
Deal and financing activity
Relevant licensing deals, acquisitions, and financings in the space. Terms when public, strategic context, and what the pattern signals for your fundraise or partner strategy.
Optional: ongoing monitoring
Quarterly or monthly updates on competitor pipelines, readouts, regulatory events, and deal activity. Useful when the space is moving and decisions need to keep pace.
Who it's for
The service adapts to who is reading the output
Biotech team
Refine positioning ahead of a fundraise, partner meeting, or board update. Check where you stand before a diligence conversation.
Investor
Independent read on an asset, a sub-sector, or a fund thesis. Structured competitive context to inform an investment or pass.
BD team
Competitive diligence on a target company or deal. What the landscape says about likely value, risk, and strategic fit.
How it runs
Scope set on an intro call. Most engagements deliver in 2-4 weeks, though scope dictates timeline
Scope
Define the competitor set, modalities, indications, geographies, and questions you need answered.
Build
Structured evidence base from primary sources. SME interviews when the scope calls for it.
Deliver
Written analysis, board-ready slides, and a structured dataset. A review call to walk through findings.
Related Services
Competitive Intelligence often pairs with these engagements
Portfolio Strategy
Use competitive findings to prioritize across programs or indications.
Learn morePreclinical Strategy
Translate competitive learnings into study sequence, model choice, and go/no-go gates.
Learn moreInvestor/Partner Readiness
Fold the competitive story into a data room, narrative, and Q&A prep.
Learn moreFrequently Asked Questions
Know the landscape
Get in touch to scope the right competitive analysis
Get in touchConfidential · Response within one business day
info@bridgelinetranslational.com · bridgelinetranslational.com